| |
Records |
Links |
|
Author |
European Monitoring Centre for Drugs and Drug Addiction |
|
| |
Title |
General report of activities 2010 : including “Annual report of the EMCDDA's authorising officer” |
Type |
Report |
| |
Year |
2011 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
102 |
|
| |
Keywords |
monitoring; administration and management; cost-effectiveness; cooperation; communication; quality control; assessment; policy recommendations; European Monitoring Centre for Drugs and Drug Addiction (body); international area; Europe; annual report |
|
| |
Abstract |
The General report of activities is an annual publication providing a detailed progress report of the EMCDDA’s activities over a 12-month period. It catalogues the Centre’s achievements in each area of its annual work programme. The report is a useful information source for all those seeking comprehensive information on the Centre and its work. |
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
Office for Official Publications of the European Communities |
Place of Publication |
Luxembourg |
Editor |
|
|
| |
Language |
English |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
General report of activities |
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN  |
1725-4558 |
ISBN |
978-92-9168-461-8 |
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
|
Approved |
no |
|
| |
Call Number |
50-12602 |
Serial |
50964 |
|
| Permanent link to this record |
| |
|
| |
|
Author |
European Monitoring Centre for Drugs and Drug Addiction |
|
| |
Title |
General report of activities 2011 : key achievements and governance : a year in review |
Type |
Report |
| |
Year |
2012 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
100 |
|
| |
Keywords |
monitoring; administration and management; financial management; cost-effectiveness; cooperation; communication; quality control; assessment; policy recommendations; financial statement; European Monitoring Centre for Drugs and Drug Addiction (body); international area; Europe; annual report |
|
| |
Abstract |
The General report of activities is an annual publication providing a detailed progress report of the EMCDDA’s activities over a 12-month period. It catalogues the Centre’s achievements in each area of its annual work programme. The report is a useful information source for all those seeking comprehensive information on the Centre and its work. |
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
Office for Official Publications of the European Communities |
Place of Publication |
Luxembourg |
Editor |
|
|
| |
Language |
English |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
General report of activities |
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
1725-4558 |
ISBN |
978-92-9168-505-9 |
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
|
Approved |
no |
|
| |
Call Number |
50-12603 |
Serial |
50965 |
|
| Permanent link to this record |
| |
|
| |
|
Author |
European Monitoring Centre for Drugs and Drug Addiction |
|
| |
Title |
General report of activities 2012 : key achievements and governance : a year in review |
Type |
Report |
| |
Year |
2013 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
105 |
|
| |
Keywords |
monitoring; AOD use, abuse, and dependence; psychoactive substances; AOD demand; intervention (persuasion to treatment); treatment and maintenance; epidemiology; AODR disorder; AODR mortality; research; administration and management; financial management; cost-effectiveness; quality control; assessment; evaluation; cooperation; collaboration; international area; Europe; European Monitoring Centre for Drugs and Drug Addiction (body); annual report; financial statement |
|
| |
Abstract |
The General report of activities is an annual publication providing a detailed progress report of the EMCDDA’s activities over a 12-month period. It catalogues the Centre’s achievements in each area of its annual work programme. The report is a useful information source for all those seeking comprehensive information on the Centre and its work. |
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
Office for Official Publications of the European Communities |
Place of Publication |
Luxembourg |
Editor |
|
|
| |
Language |
English |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
General report of activities |
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
1725-4558 |
ISBN |
978-92-9168-657-2 |
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
|
Approved |
no |
|
| |
Call Number |
50-13067 |
Serial |
51069 |
|
| Permanent link to this record |
| |
|
| |
|
Author |
European Monitoring Centre for Drugs and Drug Addiction |
|
| |
Title |
Report on the risk assessment of PMMA in the framework of the joint action on new synthetic drugs |
Type |
Report |
| |
Year |
2003 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
122 |
|
| |
Keywords |
amphetamines; monitoring; risk assessment; designer drug; research chemical; report; Europe |
|
| |
Abstract |
The report assesses the risks of PMMA, especially in association with the already controlled substance PMA (para-methoxyamphetamine). PMMA, is an amphetamine-like substance very close to PMA, and is almost exclusively sold in tablet form in combination with the latter and consumed as ‘ecstasy’. It has been associated, in combination with PMA, with three deaths in the EU. PMMA is devoid of any therapeutic value. Further to the conclusions of the EMCDDA risk assessment, on 28 February 2002, the Council of the European Union adopted a unanimous decision defining the new synthetic drug PMMA (para-methoxymethylamphetamine) as a substance to be placed under control measures and criminal penalties in the EU Member States. |
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
Office for Official Publications of the European Communities |
Place of Publication |
Luxemburg |
Editor |
|
|
| |
Language |
English |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
Risk assessments |
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
1725-4485 |
ISBN |
92-9168-137-7 |
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
|
Approved |
no |
|
| |
Call Number |
50-13429 |
Serial |
50464 |
|
| Permanent link to this record |
| |
|
| |
|
Author |
European Monitoring Centre for Drugs and Drug Addiction |
|
| |
Title |
Report on the risk assessment of ketamine in the framework of the joint action on new synthetic drugs |
Type |
Report |
| |
Year |
2002 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
116 |
|
| |
Keywords |
ketamine; monitoring; risk assessment; designer drug; research chemical; report; Europe |
|
| |
Abstract |
Since the mid-1990s, ketamine – widely used in human and veterinary medicine for 30 years – has been surfacing as a recreational drug. Concern over ketamine centres on its unpredictability in producing ‘near-death’ experiences. The risk-assessment exercise was carried out in 2000 in the framework of the Joint action on new synthetic drugs. In March 2001, the EU Justice and Home Affairs Council adopted formal conclusions that Member States should monitor this drug closely. This publication records the findings and conclusions of the exercise. Among others, it draws together the various elements used to assess the substance including: the final risk-assessment report; contributions from Europol and the European Agency for the Evaluation of Medicinal Products; a review of pharmacotoxicological data; epidemiological evidence on the associated public-health risks and sociological and criminological evidence. |
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
Office for Official Publications of the European Communities |
Place of Publication |
Luxembourg |
Editor |
|
|
| |
Language |
English |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
1725-4485 |
ISBN |
92-9168-123-7 |
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
|
Approved |
no |
|
| |
Call Number |
50-13430 |
Serial |
50465 |
|
| Permanent link to this record |
| |
|
| |
|
Author |
European Monitoring Centre for Drugs and Drug Addiction |
|
| |
Title |
Report on the risk assessment of GHB in the framework of the joint action on new synthetic drugs |
Type |
Report |
| |
Year |
2002 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
92 |
|
| |
Keywords |
amphetamines; gamma-hydroxybutyric acid; monitoring; risk assessment; designer drug; research chemical; report; Europe |
|
| |
Abstract |
Since the mid-1990s, GHB – widely used in human and veterinary medicine for 30 years – has been surfacing as a recreational drug. Some EU countries have reported worries over GHB’s surreptitious use in sexual assaults. Although the extent of this is unknown, the EMCDDA and its risk-assessment partners are recommending that Member States consider the role of GHB and other drugs in this area. The risk-assessment exercise was carried out in 2000 in the framework of the Joint action on new synthetic drugs. In March 2001, the EU Justice and Home Affairs Council adopted formal conclusions that Member States should monitor this drug closely. This publication records the findings and conclusions of the exercise. Among others, it draws together the various elements used to assess the substance including: the final risk-assessment report; contributions from Europol and the European Agency for the Evaluation of Medicinal Products; a review of pharmacotoxicological data; epidemiological evidence on the associated public-health risks and sociological and criminological evidence. |
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
Office for Official Publications of the European Communities |
Place of Publication |
Luxembourg |
Editor |
|
|
| |
Language |
English |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
Risk assessments |
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
1725-4485 |
ISBN |
92-9168-122-9 |
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
|
Approved |
no |
|
| |
Call Number |
50-13431 |
Serial |
50466 |
|
| Permanent link to this record |
| |
|
| |
|
Author |
European Monitoring Centre for Drugs and Drug Addiction |
|
| |
Title |
Report on the risk assessment of BZP in the framework of the Council decision on new psychoactive substances |
Type |
Report |
| |
Year |
2009 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
91 |
|
| |
Keywords |
risk assessment; report; Europe |
|
| |
Abstract |
This publication presents the findings of the formal risk assessment on BZP, produced in 2007 by the Scientific Committee of the EMCDDA, with participation of additional experts from the European Commission, Europol and the EMEA. The risk assessment report, which was submitted to the European Commission and the Council of the European Union on 31 May 2007, examines the health and social risks of the drug, as well as information on international trafficking and the involvement of organised crime. Furthermore, the report considers the potential implications for placing the drug under control in the EU. On the basis of this report — and on the initiative of the European Commission — on 3 March 2008, the Council decided that BZP is to be subject to control measures. |
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
Office for Official Publications of the European Communities |
Place of Publication |
Luxemburg |
Editor |
|
|
| |
Language |
English |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
Risk assessments |
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
1725-4485 |
ISBN |
978-92-9168-345-1 |
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
|
Approved |
no |
|
| |
Call Number |
50-10526 |
Serial |
50726 |
|
| Permanent link to this record |
| |
|
| |
|
Author |
European Monitoring Centre for Drugs and Drug Addiction |
|
| |
Title |
Report on the risk assessment of mephedrone in the framework of the council decision on new psychoactive substances |
Type |
Report |
| |
Year |
2011 |
Publication |
|
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
|
Pages |
193 |
|
| |
Keywords |
psychoactive substances; mephedrone; monitoring; risk assessment; report; Europe |
|
| |
Abstract |
This publication presents the summary findings and the conclusions of the risk assessment on mephedrone, carried out by the EMCDDA’s extended Scientific Committee, with participation of additional experts from the European Commission, Europol and the EMA. The risk assessment report, which was submitted to the European Commission and the Council of the European Union 26 May 2010, examines the health and social risks of the drug, as well as information on international trafficking and the involvement of organised crime. Furthermore, the report considers the potential implications for placing the drug under control in the EU. On the basis of this report – and on the initiative of the European Commission – on 2 December 2010, the Council decided that mephedrone is to be subject to control measures. |
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
Office for Official Publications of the European Communities |
Place of Publication |
Luxembourg |
Editor |
|
|
| |
Language |
English |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
Risk assessments |
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
1725-4485 |
ISBN |
978-929168457-1 |
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
|
Approved |
no |
|
| |
Call Number |
50-11829 |
Serial |
50848 |
|
| Permanent link to this record |
| |
|
| |
|
Author |
European Union |
|
| |
Title |
Council : EU drugs action plan for 2009-2012 |
Type |
Journal Article |
| |
Year |
2008 |
Publication |
Official Journal of the European Union |
Abbreviated Journal |
|
|
| |
Volume |
51 |
Issue |
C 326; 20.12.2008 |
Pages |
7-25 |
|
| |
Keywords |
government and politics; Europe |
|
| |
Abstract |
|
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
|
Place of Publication |
|
Editor |
|
|
| |
Language |
English |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
1725-2423 |
ISBN |
|
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
|
Approved |
no |
|
| |
Call Number |
50-10420 |
Serial |
59372 |
|
| Permanent link to this record |
| |
|
| |
|
Author |
Europäische Union |
|
| |
Title |
Rat : EU-Drogenaktionsplan (2005-2008) |
Type |
Journal Article |
| |
Year |
2005 |
Publication |
Amtsblatt der Europäischen Union |
Abbreviated Journal |
|
|
| |
Volume |
|
Issue |
C 168; 08.07.2005 |
Pages |
1-18 |
|
| |
Keywords |
government and politics; Europe |
|
| |
Abstract |
|
|
| |
Address |
|
|
| |
Corporate Author |
|
Thesis |
|
|
| |
Publisher |
|
Place of Publication |
|
Editor |
|
|
| |
Language |
German |
Summary Language |
|
Original Title |
|
|
| |
Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
|
| |
Series Volume |
|
Series Issue |
|
Edition |
|
|
| |
ISSN |
1725-2407 |
ISBN |
|
Medium |
|
|
| |
Area |
|
Expedition |
|
Conference |
|
|
| |
Notes |
|
Approved |
no |
|
| |
Call Number |
50-10419 |
Serial |
59371 |
|
| Permanent link to this record |
